Affilogic
Victor Roullier is a seasoned professional in the field of process and formulation development, currently serving as a Project Manager at Affilogic since March 2024, focusing on the process development of Nanofitins conjugation to drugs and nanoparticles. Prior experience includes serving as Process and Formulation Development Manager at Phercydes Pharma, where responsibilities encompassed upstream production and downstream purification of bacteriophages. Earlier roles include Project Manager at Capsulae, overseeing R&D on encapsulation processes for various active ingredients, and Research Engineer in protein formulation at Flamel Technologies, where the formulation of therapeutic proteins was a key focus. Victor Roullier holds a PhD in Physico-Chemistry from Université de Rennes 1 and has garnered a breadth of experience in the pharmaceutical industry through various positions, including an internship at sanofi-aventis. Academic credentials include degrees from multiple prestigious institutions, culminating in a comprehensive background in chemistry and biochemistry.
This person is not in any teams
Affilogic
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).